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To the Editor—Multidrug-resistant organisms (MDROs) are
responsible for an increasing number of infections each year.1
An oft-cited statistic is that MDRO infections cause > 2 million
illnesses and 23,000 deaths each year in the United States.1
However, the true burden of MDRO infections remains uncertain due to insufficient national reporting rates and an absence of
ICD-10 codes specifically for MDRO infections. Therefore, we
sought to provide an updated estimate of deaths due to MDRO
infections in the United States. Based on availability of data, we
provide an estimation of mortality from MDROs for the
year 2010.
In 2010 in the United States, 2,468,435 deaths were registered,2
of which 715,000 (29.0%) were inpatient hospital deaths.3 Using a
conservative estimate for deaths due to sepsis,4 34.4% of inpatient
deaths occur among patients with sepsis,5 and the reported rate of
MDR pathogens in sepsis is 28.8%.6 With these parameters,
MDRO sepsis could cause 70,837 inpatient deaths each year
(Table 1).
We have yet to assign infection as a cause of death to the
1,753,435 outpatient deaths in 2010. Subtracting deaths that are
unlikely to be due to infection (eg, suicides, accidents, and
homicides), we are left with 1,572,624 deaths. After subtracting
deaths due to infections, 1,550,536 deaths remain. If 17%–19%
of these 1,550,536 deaths are due to infections (despite
not being indexed as such)7 and 28.8% are due to MDROs,
there would be 285,680–316,690 deaths in which infection
contributed to death, of which 82,276–91,207 deaths were due
to MDROs (Table 1).
Summing the lower bounds of our estimates for inpatient
and outpatient deaths due to MDRO infections gives us
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Table 1. Estimates of Number of Deaths Due to Infection and MultidrugResistant Organisms in the United States in 2010

Category

Deaths Due to Infection

Deaths Due to MultidrugResistant Organism Infection

Inpatient

245,960

70,837

Outpatient

285,680–316,690

82,276–91,207

Total

531,640–562,650

153,113–162,044

153,113 deaths, a number almost 7-fold higher than that
estimated by the CDC (ie, ~ 23,000).1 Assuming a worst-case
scenario and summing the upper limits of our estimate,
162,044 deaths in the United States were due to MDRO
infections in 2010 (Table 1). This would move MDRO
infections to the third highest cause of death in the United
States for 2010. All infections would then supersede the
MDRO infections group as the third highest cause of death, 2
with > 500,000 (Table 1).
Our estimates illustrate a need for better surveillance and
reporting mechanisms for MDRO infections. With rampant overuse of antibiotics, establishment of MDRO breeding and transmission centers (long-term acute-care hospitals and nursing
facilities), and increasing rates of iatrogenic immunosuppression,
the population at risk for MDRO infections and the likelihood of
drug resistance will continue to increase. To address this critical
issue, establishing the burden of MDROs is crucial to guide
research funding allocation.
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Affected healthcare workers during outbreaks: A report from
the German consulting center for infection control (BZH)
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Dr. med. habil.
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To the Editor—In 2013, the outbreak registry of the German
consulting center for infection control and prevention (Deutsches
Beratungszentrum für Hygiene, BZH GmbH, Freiburg, Germany)
was instituted as a quality assurance project to analyze outbreak
situations to gain epidemiological data and to generate practical
advice for the affected institutions. After 5 years, the registry now
contains data for 96 outbreaks plus final analyses. Here, we
focused on outbreaks affecting healthcare workers (HCWs) as
part of the infected or colonized outbreak cohort.

colonization outbreaks without infections if they required comprehensive infection control interventions.
Data from the outbreak analysis were entered without personal
identifiers in an anonymized database according to European
Union’s (EU) General Data Protection Regulation (GDPR). This
was not human research, and data analysis does not require review
by our institutional review board. Overall, 94 outbreaks were analyzed regarding information related to involvement of HCWs.

Results
Material and Methods
In contrast to the German legal definition (German infection
prevention law, Infektionsschutzgesetz), which defines 2 or more
cases of infection with a presumed epidemiological link as an
outbreak, our registry only includes “major” outbreaks, which are
defined as 5 or more cases of infection or colonization with an
epidemiological link or, in cases of special organisms like
multidrug-resistant organisms (MDROs), highly contagious diseases with 2 or more cases or sentinel cases of special interest.1
The definition was chosen to limit the analytical effort on common outbreaks (eg, with norovirus) to major events but to include
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The 94 screened outbreaks involved 464 people with infections
and 168 with colonization only. The duration of the outbreak
management ranged from 1 day to 185 days; the number of
affected people ranged from 1 to 66 per outbreak. Figure 1
shows the distribution of organisms involved and their
relation to outbreaks of infections (59%), combined outbreaks
with infections and colonizations (20%), and colonization
only (21%).
Overall, 192 HCWs became sick as part of an outbreak: 162
had norovirus infections, 22 had influenza infections, 8 had
scabies infections. Furthermore, 2 HCWs were found to be
colonized with MRSA in the screenings performed during an
outbreak. No clear epidemiological link was identified between
MRSA colonization status and the outbreak in 1 case, whereas
an HCW was identified as superspreader during an upper
respiratory tract infection in the other. In 5 outbreaks with
gram-negative MDROs and 1 VRE outbreak, rectal screening of
staff was performed without any meaningful results.

